Moscow, Russia
Russia announced that it is planning to complete the development of an mRNA cancer vaccine and launch it in 2025. 
"Russia has developed its own mRNA vaccine against cancer, it will be distributed to patients free of charge, General Director of the Radiology Medical Research Center of the Russian Ministry of Health, Andrey Kaprin, has told Radio Rossiya," reported Russian news agency TASS.
In the pre-clinical trials, tumour suppression and metastasis reduction were demonstrated by the vaccine. The integration of artificial intelligence further paved the way for personalising vaccine creation in an hour and accelerating the current process, which is lengthy. 
The vaccine is aimed at bolstering the ability of the immune system and eliminating cancer cells.
Also Read: <a href="https://www.wionews.com/world/wuhan-lab-leak-likely-behind-covid-pandemic-finds-us-investigation-780981">Wuhan lab leak likely behind Covid pandemic, finds US investigation</a>
Speaking to TASS, Director of the Gamaleya National Research Center for Epidemiology and Microbiology, Alexander Gintsburg, confirmed that the vaccine will be brought into general circulation in early 2025. 
"The vaccine’s pre-clinical trials had shown that it suppresses tumour development and potential metastases," Gintsburg said to TASS.
The experts had developed the vaccine in collaboration with various research centres. 
<h2>How do vaccines combat cancer cells?</h2>
Vaccines stimulate the immune system in a way that it can recognise and attack cancer cells.
Watch: Trump Takes on Huge, Rich Vaccine Industrial Complex, Elects Anti-vaxxer Dr Oz 
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://cdn.thepublive.com/wion/static/kaltura_player/wion_video_player_iframe.html?thumbnail=wion/media/post_attachments/files/2024/11/20/2011_WION_TRUMP_9PM-1732124728-00000003.jpg&videourl=https://vodakm.zeenews.com/vod/WION/2011_WION_TRUMP_9PM.mp4/index.m3u8&duration=343&tags=US,Donald Trump,dr mehmet oz,gravitas" style="width:100%;max-width:560px;" width="560"></iframe></div>
Specific proteins or antigens in tumour cells are targeted by therapeutic cancer vaccines as they train the immune system to identify and destroy them.
Few vaccines use modified or weakened viruses for delivering the antigens, which leads to a strong immune response. 
However, preventive vaccines like the HPV vaccine are able to protect against viruses related to cancer, which decreases the risk of some kinds of cancers, like cervical cancer.
The vaccines enhance the natural defences of the body and slow down the growth of tumours, which prevents recurrence and also eliminates early-stage cancers. 
(With inputs from agencies)

Russia has said that it plans to launch the mRNA cancer vaccine in 2025. The vaccine is aimed at bolstering the ability of the immune system and eliminating cancer cells

 



Moscow, Russia Russia announced that it is planning to complete the development of an mRNA cancer vaccine and launch it in 2025. "Russia has developed its own mRNA vaccine against cancer, it will be distributed to patients free of charge, General Director of the Radiology Medical Research Center of the Russian Ministry of Health, Andrey Kaprin, has told Radio Rossiya," reported Russian news agency TASS. In the pre-clinical trials, tumour suppression and metastasis reduction were demonstrated by the vaccine. The integration of artificial intelligence further paved the way for personalising vaccine creation in an hour and accelerating the current process, which is lengthy. The vaccine is aimed at bolstering the ability of the immune system and eliminating cancer cells. Also Read: Wuhan lab leak likely behind Covid pandemic, finds US investigation Speaking to TASS, Director of the Gamaleya National Research Center for Epidemiology and Microbiology, Alexander Gintsburg, confirmed that the vaccine will be brought into general circulation in early 2025. "The vaccine’s pre-clinical trials had shown that it suppresses tumour development and potential metastases," Gintsburg said to TASS. The experts had developed the vaccine in collaboration with various research centres. How do vaccines combat cancer cells? Vaccines stimulate the immune system in a way that it can recognise and attack cancer cells. Watch: Trump Takes on Huge, Rich Vaccine Industrial Complex, Elects Anti-vaxxer Dr Oz Specific proteins or antigens in tumour cells are targeted by therapeutic cancer vaccines as they train the immune system to identify and destroy them. Few vaccines use modified or weakened viruses for delivering the antigens, which leads to a strong immune response. However, preventive vaccines like the HPV vaccine are able to protect against viruses related to cancer, which decreases the risk of some kinds of cancers, like cervical cancer. The vaccines enhance the natural defences of the body and slow down the growth of tumours, which prevents recurrence and also eliminates early-stage cancers. (With inputs from agencies)

Russia develops its own cancer vaccine, plans to distribute it for free

Russia announced that it is planning to complete the development of an mRNA cancer vaccine and launch it in 2025.&nbsp;

"Russia has developed its own mRNA vaccine against cancer, it will be distributed to patients free of charge, General Director of the Radiology Medical Research Center of the Russian Ministry of Health, Andrey Kaprin, has told Radio Rossiya," reported Russian news agency TASS.

In the pre-clinical trials, tumour suppression and metastasis reduction were demonstrated by the vaccine. The integration of artificial intelligence further paved the way for personalising vaccine creation in an hour and accelerating the current process, which is lengthy.&nbsp;

The vaccine is aimed at bolstering the ability of the immune system and eliminating cancer cells.

Also Read:&nbsp;<a href="https://www.wionews.com/world/wuhan-lab-leak-likely-behind-covid-pandemic-finds-us-investigation-780981">Wuhan lab leak likely behind Covid pandemic, finds US investigation</a>

Speaking to TASS, Director of the Gamaleya National Research Center for Epidemiology and Microbiology, Alexander Gintsburg, confirmed that the vaccine will be brought into general circulation in early 2025.&nbsp;

"The vaccine’s pre-clinical trials had shown that it suppresses tumour development and potential metastases," Gintsburg said to TASS.

The experts had developed the vaccine in collaboration with various research centres.&nbsp;

<h2>How do vaccines combat cancer cells?</h2>

Vaccines stimulate the immune system in a way that it can recognise and attack cancer cells.

Watch:&nbsp;Trump Takes on Huge, Rich Vaccine Industrial Complex, Elects Anti-vaxxer Dr Oz&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/trump-takes-on-huge-rich-vaccine-industrial-complex-elects-anti-vaxxer-dr-oz-gravitas-777819/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

Specific proteins or antigens in tumour cells are targeted by therapeutic cancer vaccines as they train the immune system to identify and destroy them.

Few vaccines use modified or weakened viruses for delivering the antigens, which leads to a strong immune response.&nbsp;

However, preventive vaccines like the HPV vaccine are able to protect against viruses related to cancer, which decreases the risk of some kinds of cancers, like cervical cancer.

The vaccines enhance the natural defences of the body and slow down the growth of tumours, which prevents recurrence and also eliminates early-stage cancers.&nbsp;

(With inputs from agencies)

Russia announced that it is planning to complete the development of an mRNA cancer vaccine and launch it in 2025. "Russia has developed its own mRNA vaccine against cancer, it will be distributed to patients free of charge, General Director of the Radiology Medical Research Center of the Russian Ministry of Health, Andrey Kaprin, has told Radio Rossiya," reported Russian news agency TASS.

Russia announced that it is planning to complete the development of an mRNA cancer vaccine and launch it in 2025. "Russia has developed its own mRNA vaccine against cancer, it will be distributed to patients free of charge, General Director of the Radiology Medical Research Center of the Russian Ministry of Health, Andrey Kaprin, has told Radio Rossiya," reported Russian news agency TASS. In the pre-clinical trials, tumour suppression and metastasis reduction were demonstrated by the vaccine. The integration of artificial intelligence further paved the way for personalising vaccine creation in an hour and accelerating the current process, which is lengthy. The vaccine is aimed at bolstering the ability of the immune system and eliminating cancer cells. Also Read: Wuhan lab leak likely behind Covid pandemic, finds US investigation Speaking to TASS, Director of the Gamaleya National Research Center for Epidemiology and Microbiology, Alexander Gintsburg, confirmed that the vaccine will be brought into general circulation in early 2025. "The vaccine’s pre-clinical trials had shown that it suppresses tumour development and potential metastases," Gintsburg said to TASS. The experts had developed the vaccine in collaboration with various research centres. How do vaccines combat cancer cells? Vaccines stimulate the immune system in a way that it can recognise and attack cancer cells. Watch: Trump Takes on Huge, Rich Vaccine Industrial Complex, Elects Anti-vaxxer Dr Oz Specific proteins or antigens in tumour cells are targeted by therapeutic cancer vaccines as they train the immune system to identify and destroy them. Few vaccines use modified or weakened viruses for delivering the antigens, which leads to a strong immune response. However, preventive vaccines like the HPV vaccine are able to protect against viruses related to cancer, which decreases the risk of some kinds of cancers, like cervical cancer. The vaccines enhance the natural defences of the body and slow down the growth of tumours, which prevents recurrence and also eliminates early-stage cancers. (With inputs from agencies)

Paul Edmonds, a man from the US state of California has been free of both cancer and HIV since one particular treatment five years ago known as a stem cell transplant. In 2021, he also became one of&nbsp;five people in the world who had been cured of HIV.&nbsp;

<h2>About Edmonds’ journey</h2>

Sharing his story with the National Cancer Institute, City of Hope, Edmonds said that he had been living with HIV-1 for 31 years before the transplant. “People were dying within a few years of finding out they were positive,” said Edmonds recalling reading the obituaries of many friends back in the early 1980s.&nbsp;

Also Read |&nbsp;<a href="https://www.wionews.com/trending/norovirus-is-spreading-in-us-states-cdc-data-shows-heres-all-you-need-to-know-about-the-zoonotic-disease-693380">Norovirus spreading in US states, shows CDC data. Here's all you need to know about the zoonotic disease</a>

“A dark cloud was over the city,” he said, describing the city of San Francisco. At the time, people didn’t know what his friends were dying from but many called it AIDS. However, it was not until 1984 that HIV was identified as the cause of AIDS.&nbsp;

Edmonds was diagnosed in 1988 with not just HIV, but full-blown AIDS. He told the City of Hope, that he felt he had been given a death sentence. In 1997, he began HIV antiretroviral therapy which effectively suppressed the virus to undetectable levels, but it is not a cure.&nbsp;

In 2018, Edmonds was diagnosed with myelodysplastic syndrome, which eventually developed into acute myeloid leukaemia (AML). Since people with HIV have weaker immune systems, they are likely to develop leukaemia and other blood cancers.&nbsp;

<h2>About the treatment</h2>

Edmonds has been free of both cancer and HIV since one particular treatment and is now considered in remission from AML and in another two years, he will be considered “cured” of HIV, since it would mark five years from his last treatment.&nbsp;

He is not only the fifth person in the world in remission of HIV, but also the eldest and had HIV the longest. Edmonds, 67, and his husband, Arnie House, were both HIV-positive when they were first diagnosed over three decades ago.&nbsp;

“I wasn’t ready to die,” he told ABC News, speaking about his miraculous treatment at City of Hope. The medical team behind his case published his stunning recovery in the New England Journal of Medicine.

Also Read |<a href="https://www.wionews.com/india-news/india-first-commercial-patient-declared-cancer-free-using-indigenous-car-t-cell-therapy-687858">&nbsp;India: First patient declared ‘cancer-free’ using indigenous CAR-T cell therapy</a>

The treatment behind the remission is known as a stem cell transplant and is typically used in the final part of treatment for blood cancers, including leukaemia.&nbsp;

As a part of the treatment, blood-forming stem cells in a patient’s bone marrow are destroyed using radiation or chemotherapy and the patient is then injected with healthy blood-forming stem cells.&nbsp;

The stem cells are taken from a donor who has similar – but not the same – genes and are transplanted into the patient. These cells then produce cancer-free blood. However, in Edmonds’ case, the donated stem cells had a genetic mutation associated with resistance to HIV-1, said the doctors.&nbsp;

“It’s a very rare mutation. It exists in roughly 1% of the population,” said Dr Jana Dickter, Edmond’s physician at City of Hope, as quoted by the New York Post. “It’s not something we find very commonly.”

The transplant replaced Edmonds’ bone marrow and blood stem cells with the donors’ and since then he has shown no signs of either AML or HIV.&nbsp;

(With inputs from agencies) 
&nbsp;

Paul Edmonds, a man from the US state of California has been free of both cancer and HIV since one particular treatment five years ago known as a stem cell transplant.

Paul Edmonds, a man from the US state of California has been free of both cancer and HIV since one particular treatment five years ago known as a stem cell transplant. In 2021, he also became one of five people in the world who had been cured of HIV. About Edmonds’ journey Sharing his story with the National Cancer Institute, City of Hope, Edmonds said that he had been living with HIV-1 for 31 years before the transplant. “People were dying within a few years of finding out they were positive,” said Edmonds recalling reading the obituaries of many friends back in the early 1980s. Also Read | Norovirus spreading in US states, shows CDC data. Here's all you need to know about the zoonotic disease “A dark cloud was over the city,” he said, describing the city of San Francisco. At the time, people didn’t know what his friends were dying from but many called it AIDS. However, it was not until 1984 that HIV was identified as the cause of AIDS. Edmonds was diagnosed in 1988 with not just HIV, but full-blown AIDS. He told the City of Hope, that he felt he had been given a death sentence. In 1997, he began HIV antiretroviral therapy which effectively suppressed the virus to undetectable levels, but it is not a cure. In 2018, Edmonds was diagnosed with myelodysplastic syndrome, which eventually developed into acute myeloid leukaemia (AML). Since people with HIV have weaker immune systems, they are likely to develop leukaemia and other blood cancers. About the treatment Edmonds has been free of both cancer and HIV since one particular treatment and is now considered in remission from AML and in another two years, he will be considered “cured” of HIV, since it would mark five years from his last treatment. He is not only the fifth person in the world in remission of HIV, but also the eldest and had HIV the longest. Edmonds, 67, and his husband, Arnie House, were both HIV-positive when they were first diagnosed over three decades ago. “I wasn’t ready to die,” he told ABC News, speaking about his miraculous treatment at City of Hope. The medical team behind his case published his stunning recovery in the New England Journal of Medicine. Also Read | India: First patient declared ‘cancer-free’ using indigenous CAR-T cell therapy The treatment behind the remission is known as a stem cell transplant and is typically used in the final part of treatment for blood cancers, including leukaemia. As a part of the treatment, blood-forming stem cells in a patient’s bone marrow are destroyed using radiation or chemotherapy and the patient is then injected with healthy blood-forming stem cells. The stem cells are taken from a donor who has similar – but not the same – genes and are transplanted into the patient. These cells then produce cancer-free blood. However, in Edmonds’ case, the donated stem cells had a genetic mutation associated with resistance to HIV-1, said the doctors. “It’s a very rare mutation. It exists in roughly 1% of the population,” said Dr Jana Dickter, Edmond’s physician at City of Hope, as quoted by the New York Post. “It’s not something we find very commonly.” The transplant replaced Edmonds’ bone marrow and blood stem cells with the donors’ and since then he has shown no signs of either AML or HIV. (With inputs from agencies)

California man ‘cured’ of cancer and HIV after stem cell treatment in stunning medical recovery

cancer-95452

Cancer (95452, News on Cancer (95452, stories on Cancer (95452, articles on Cancer (95452, Cancer (95452 stories at Wion, Cancer (95452 news, Cancer (95452 latest news

cancer 95452

Russia develops its own cancer vaccine, plans to distribute it for free

Russia develops its own cancer vaccine, plans to distribute it for free

California man ‘cured’ of cancer and HIV after stem cell treatment in stunning medical recovery